文献速递泌尿生殖技术与安全PETCT

双时间点18F-FDG PET/CT显像在鉴别膀胱尿路上皮癌淋巴结转移与反应性增生中的价值

The Value of Dual Time Point 18F-FDG PET/CT Imaging in Differentiating Lymph Node Metastasis From Reactive Hyperplasia in Bladder Urothelial Carcinoma.
PubMed 文献 · Acad Radiol · 2024-03-01

研究纳入153例膀胱癌患者的250枚淋巴结,分析18F-FDG PET/CT延迟利尿显像前后SUVmax、SUVmean、MTV及延迟指数的鉴别价值;延迟显像以SUVmax 2.0或2.5为阈值使转移淋巴结检出率分别提高4.1%和6.9%;淋巴结短轴直径、SUVmean和MTV延迟指数为独立预测因子,联合鉴别性能更优。

要点

  • 延迟显像以SUVmax 2.0为阈值使转移淋巴结检出率提高4.1%,以2.5为阈值提高6.9%。
  • 反应性增生淋巴结延迟显像常呈斑点状放射性浓聚,转移淋巴结呈整个淋巴结FDG摄取增高。
  • 淋巴结短轴直径、SUVmean和MTV延迟指数为鉴别转移与增生的独立预测因子,联合性能更优。

核心结论

  • 双时间点显像可检出更多转移淋巴结;部分增生淋巴结在延迟显像上呈斑点状放射性浓聚;淋巴结短轴直径、SUVmean和DIMTV是预测淋巴结转移的三个重要参数。

研究设计与样本

  • 研究分析了153例膀胱癌患者行18F-FDG PET/CT延迟利尿显像的250枚淋巴结,获取延迟显像前后的SUVmax、SUVmean、MTV及相关延迟指数,采用非参数检验和多因素分析,并绘制受试者工作特征曲线和列线图预测淋巴结转移。

关键影像表现/征象

  • 延迟PET/CT显像对增生性和转移性淋巴结的检出均更好;延迟显像上反应性增生淋巴结常表现为斑点状放射性浓聚,转移淋巴结表现为整个淋巴结FDG摄取增高。

诊断标准与关键数值

  • 延迟显像以SUVmax 2.0为阈值使转移淋巴结检出率提高4.1%,以SUVmax 2.5为阈值提高6.9%;淋巴结短轴直径、SUVmean和DIMTV为独立预测因子,三者联合的鉴别性能优于单个预测因子;在高风险患者中淋巴结转移概率高达97.6%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: This study explored the clinical value of dual time-point 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET) imaging for differentiating lymph node metastasis from lymph nodes with reactive hyperplasia.

METHODS: 250 lymph nodes from 153 bladder cancer patients who underwent 18F-FDG PET/computed tomography (CT) delayed diuretic imaging were analyzed. The maximum and mean standardized uptake values (SUVmax and SUVmean, respectively), metabolic tumor volume (MTV), and related delay indices before and after PET delayed imaging were obtained. Relationships with outcomes were analyzed using nonparametric and multivariate analyses. Receiver operating characteristic curves and nomograms were drawn to predict lymph node metastasis.

RESULTS: Delayed PET/CT imaging showed better detection of hyperplasia and metastatic lymph nodes. Delayed imaging with a cutoff SUVmax of 2.0 or 2.5 increased the detection rate of metastatic lymph nodes by 4.1%, and 6.9%, respectively. Delayed imaging often showed speckle-like radioactive foci in lymph nodes with reactive hyperplasia and increased FDG uptake throughout the nodes in metastatic lymph nodes. The lymph node short-axis diameter, SUVmean, and delayed index of MTV (DIMTV) were independent predictors for differentiating metastatic lymph nodes from reactive hyperplasia, and their combination showed better differentiation performance than the individual predictors. In high-risk patients, the probability of lymph node metastasis was as high as 97.6%.

CONCLUSION: Dual time-point imaging can detect more metastatic lymph nodes. Some lymph nodes with hyperplasia show speckle-like radioactive foci on delayed imaging. The lymph node short-axis diameter, SUVmean, and DIMTV are three important parameters for predicting lymph node metastasis.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Zhou X, Lu Z, Zhang R, et al. The Value of Dual Time Point 18F-FDG PET/CT Imaging in Differentiating Lymph Node Metastasis From Reactive Hyperplasia in Bladder Urothelial Carcinoma. Acad Radiol. 2024. PMID: 38431484. doi:10.1016/j.acra.2024.02.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。